Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 39,500 shares at $59.60 ($2.4M) on 2020-01-06, disclosed to the SEC on 2020-01-08.
Seasonal sale ($2.4M) by Chief Financial Officer — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.60 | 7,593 | $453K | 19.1% |
| 2 | $59.60 | 7,593 | $453K | 19.1% |
| 3 | $60.40 | 11,907 | $719K | 30.3% |
| 4 | $60.40 | 11,907 | $719K | 30.3% |
| 5 | $60.95 | 500 | $30K | 1.3% |
| Total | $60.10 avg | 39,500 |
| $2.4M |
| 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |